Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

NOVO NORDISK, INC.

Filed by S-3 GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
$20,000.00
Expenses
Not reported
Registrant
S-3 GROUP
Filing UUID
7da64784-dca7-4fd1-bee1-ec9859e086d2
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to compounding and counterfeit drugs.

MMM · Medicare/Medicaid

Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.

TRD · Trade (domestic/foreign)

Issues related to tariffs and importation of counterfeit drugs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.